세계의 영상 진단 시장 규모 : 제품별, 최종 사용자별, 지역별, 범위 및 예측

Diagnostic Imaging Market Size And Forecast

Diagnostic Imaging Market size was valued at USD 26.1 Billion in 2021 and is projected to reach USD 39.9 Billion by 2030, growing at a CAGR of 5.4% from 2022 to 2030. Diagnostic imaging comprises a variety of techniques for seeing the human body to diagnose, monitor, or treat medical disorders. Each type of technology provides various information on the body part being investigated or treated, such as sickness, injury, or the efficacy of medical treatment. The Global Diagnostic Imaging Market is expanding due to an increase in the geriatric population, greater usage of modern medical imaging technology, technological advancements, a rising need for improved optical imaging for better health and disease diagnosis, and a surge in the incidence of chronic disorders. The Global Diagnostic Imaging Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Diagnostic Imaging Market Definition

Non-invasive methods of making pictures of within body structures for diagnostic and therapeutic reasons look named diagnostic or medical imaging. The most current are X-rays, resonance imaging (MRI), CT (CT), prenatal diagnosis, and different diagnostic imaging methods. Care staff uses diagnostic imaging to create correct diagnoses and examinations. Additionally, the technology is employed to rigorously monitor the patient's body's response to the treatment and drugs. Diagnostic imaging refers to numerous procedures for looking into the body to see the source of a health problem or harm and ensure a designation.

Doctors additionally assess how well a patient's body responds to fracture or illness medical care. Diagnostic imaging permits doctors to see within the body to envision whether or not there are any signs of ill health. Some devices and procedures generate pictures of your body's activities and structures. The doctor can determine that medical imaging tests are needed to support the examined piece and the symptoms. AN imaging scan provides an in-depth cross-sectional image of inner organs and structures employing a powerful magnet, radio waves, and a laptop. The scanner is often within the kind of a long tube with a table within the center wherever the patient will slide.

An imaging scan provides a detailed cross-sectional image of inner organs and structures employing a powerful magnet, radio waves, and a computer. The scanner is commonly within an elongated tube with a table within the center wherever the patient will slide. An MRI scan varies from CT scans and X-rays. As a result, it doesn't use radiation, which may be dangerous. The creation of the imaging scan is a watershed moment in medical history. Doctors, scientists, and researchers will currently use non-invasive instrumentation to examine the within of the flesh in excellent detail.

Medical practitioners use computed tomography to research structures within your body, usually CT scans. A CT scan uses X-rays and computers to form pictures of a crosswise of your body. It takes photos of your bones, muscles, organs, and blood vessels in little "pixels," so care professionals will examine your body in excellent detail. Old X-ray machines are X-ray devices that use a hard and fast tube to direct X-rays to a selected location. X-rays different absorbed in varying amounts by totally different tissues as they pass through the body. Higher-density tissue provides a whiter image on the black background of the film than different tissues.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Diagnostic Imaging Market Overview

The growing geriatric population has driven the trade. Imaging-based diagnosis has become more common as medical instrumentality has been readily offered. The rising frequency of complicated and chronic diseases has increased the market's demand for diagnostic imaging. Government and sector support and investments have aided the adoption of diagnostic imaging for better diagnosing and treatment. With age, the danger of developing diseases rises correspondingly. In keeping to the Centers for disease control and bar, about 80th of the aged in the United States suffer from at least one chronic condition (CDC).

Furthermore, the American Medical Association (AMA) expects a minimum of 60 minutes for people aged 65 and up to have several chronic conditions. Because the population ages, there'll be a more significant demand for higher care facilities, novel treatment choices, and prescribed drugs. The prevalence of age-related disorders like Alzheimer's disease, brain disease, arthritis, and dementia, similar to disorders and cancer, is foretold to rise because the global geriatric population is growing. The pandemic of COVID-19 has had both positive and harmful effects on the market. The buying power of hospitals, notably small-scale hospitals and imaging centers, is relatively forced.

Manufacturing firms have also been suffering from the pandemic. Moreover, product and repair delivery turnaround times are hindered because of current packaging standards and country-imposed opposition processes. All of those issues hurt diagnostic imaging system production and provide chains. As hospitals were required to release capability and resources for future COVID-19, the frequency of regular and elective procedures decreased significantly. As a result, the pandemic harmed the diagnostic imaging trade. This decline, however, is only probably to possess a short-run negative impact on the trade, with very little or no change within the long-run elemental forces driving diagnostic imaging device demand.

Due to the general technological restrictions related to solitary imaging modalities, researchers are hesitant to get them, limiting their market expansion. For instance, MRI takes longer to scan massive volumes of high-quality pictures; however, PET has a lesser spatial resolution. The operator depends heavily on ultrasound equipment, which needs direct contact with the body and has a restricted tissue penetration depth. SPECT has low detection sensitivity, and CT has poor soft-tissue contrast. Therefore, it provides less info regarding purposeful qualities and exposes doctors and patients to radiation. However, such imaging techniques come at a high cost, and the equipment's price may be a significant hurdle in developing countries.

Global Diagnostic Imaging Market: Segmentation Analysis

The Global Diagnostic Imaging Market is Segmented on the basis of Product, End User, And Geography.

Diagnostic Imaging Market, By Product

• Magnetic Resonance Imaging (MRI) Systems
• Computed Tomography (CT) Scanners
• Ultrasound Imaging Systems
• X-Ray Imaging Systems
• Others

Based on Product, The market is segmented into Magnetic Resonance Imaging (MRI) Systems, Computed Tomography (CT) Scanners, Ultrasound Imaging Systems, X-Ray Imaging Systems, and Others. The X-ray Imaging system category is predicted to increase the most during the forecast period, owing to the rising occurrence of orthopedic injuries and accidents, as well as the growing need for point-of-care testing, which is boosting the sale of portable equipment.

• The CT scanners category accounted for the largest share of the worldwide Diagnostic Imaging Market in 2020. The increasing demand for early and precise diagnosis, as well as the widespread usage of CT scanners by hospitals and diagnostic centers worldwide, can be attributed to the high expansion of this product category. Demand for CT scanners has gradually increased since the onset of the COVID-19 outbreak.

Diagnostic Imaging Market, By End User

• Hospitals
• Diagnostic Imaging Centers

Based on End User, The market is segmented into Hospitals and Diagnostic Imaging Centers. The hospital segment is forecasted to expand during the projected period due to increased awareness regarding health and an increased number of patients with Chronic diseases coming for treatment to the hospital.

Diagnostic Imaging Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world
• On the basis of Geography, The Global Diagnostic Imaging Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The Diagnostic Imaging Market in the Asia Pacific is predicted to grow at the fastest rate during the forecast period, owing to the growing incidence of chronic illnesses, the increase in the geriatric population, and the increased demand for enhanced imaging technologies. Moreover, an increasing number of local manufacturing units are projected to manufacture lower-priced diagnostic devices, aiding in the region's price-sensitive, underdeveloped market segment.

Key Players

• The "Global Diagnostic Imaging Market" study report will provide valuable insight with an emphasis on the global market including some of the major players such as
• Koninklijke Philips N.V., Shimadzu Corporation, Siemens Group, Hitachi Medical Systems, Carestream Health Inc., General Electric Company, Hitachi Ltd., Boston Scientific, EsaoteSpA, Canon Inc., Boston Scientific, Samsung Medison, and Fujifilm Holdings Corporation.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

• In May 2021, Royal Philips introduced the Spectrum Computed Tomography (CT) 7500, a spectral detector-based CT scanner. This new intelligent technology consistently produces high-quality spectral images for every patient on every scan, helping to enhance disease characterization and reduce rescans and follow-ups while using the same dosage levels as traditional scans.
• In April 2021, the device "single-source Nanox ARC digital X-ray technology" manufactured by NANO-X IMAGING was approved by the US Food and Drug Administration (FDA).
• In May 2020, RADLogics announced that it will be offering software to the nuance AL Marketplace. So, COVID-19 was detected using artificial intelligence-powered medical imaging apps.
• In May 2020, Life Image launched the Patient Connect Portal to give patients control over their longitudinal imaging records and medical data, which they can share with care providers.
• In February 2019, the EPIQ Elite ultrasound system was launched by Koninklijke Philips N.V., the Netherlands, for general imaging and obstetrics and gynecological applications.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL DIAGNOSTIC IMAGING MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL DIAGNOSTIC IMAGING MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL DIAGNOSTIC IMAGING MARKET, BY PRODUCT

• 5.1 Overview
• 5.2 Magnetic Resonance Imaging (MRI) Systems
• 5.3 Computed Tomography (CT) Scanners
• 5.4 Ultrasound Imaging Systems
• 5.5 X-Ray Imaging Systems
• 5.6 Others

6 GLOBAL DIAGNOSTIC IMAGING MARKET, BY END USER

• 6.1 Overview
• 6.2 Hospitals
• 6.3 Diagnostic Imaging Centers

7 GLOBAL DIAGNOSTIC IMAGING MARKET, BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5 Rest of the World
  • 7.5.1 Latin America
  • 7.5.2 Middle East and Africa

8 GLOBAL DIAGNOSTIC IMAGING MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market Ranking
• 8.3 Key Development Strategies

9 COMPANY PROFILES

• 9.1 Koninklijke Philips N.V.
  • 9.1.1 Overview
  • 9.1.2 Financial Performance
  • 9.1.3 Product Outlook
  • 9.1.4 Key Developments
• 9.2 Shimadzu Corporation
  • 9.2.1 Overview
  • 9.2.2 Financial Performance
  • 9.2.3 Product Outlook
  • 9.2.4 Key Developments
• 9.3 Siemens Group
  • 9.3.1 Overview
  • 9.3.2 Financial Performance
  • 9.3.3 Product Outlook
  • 9.3.4 Key Developments
• 9.4 Hitachi Medical Systems
  • 9.4.1 Overview
  • 9.4.2 Financial Performance
  • 9.4.3 Product Outlook
  • 9.4.4 Key Developments
• 9.5 Carestream Health Inc.
  • 9.5.1 Overview
  • 9.5.2 Financial Performance
  • 9.5.3 Product Outlook
  • 9.5.4 Key Developments
• 9.6 General Electric Company
  • 9.6.1 Overview
  • 9.6.2 Financial Performance
  • 9.6.3 Product Outlook
  • 9.6.4 Key Developments
• 9.7 Hitachi Ltd.
  • 9.7.1 Overview
  • 9.7.2 Financial Performance
  • 9.7.3 Product Outlook
  • 9.7.4 Key Developments
• 9.8 Boston Scientific
  • 9.8.1 Overview
  • 9.8.2 Financial Performance
  • 9.8.3 Product Outlook
  • 9.8.4 Key Developments
• 9.9 EsaoteSpA
  • 9.9.1 Overview
  • 9.9.2 Financial Performance
  • 9.9.3 Product Outlook
  • 9.9.4 Key Developments
• 9.10 Canon Inc.
  • 9.10.1 Overview
  • 9.10.2 Financial Performance
  • 9.10.3 Product Outlook
  • 9.10.4 Key Developments
• 9.11 Samsung Medison
  • 9.11.1 Overview
  • 9.11.2 Financial Performance
  • 9.11.3 Product Outlook
  • 9.11.4 Key Developments
• 9.12 Fujifilm Holding Corporation
  • 9.12.1 Overview
  • 9.12.2 Financial Performance
  • 9.12.3 Product Outlook
  • 9.12.4 Key Developments

10 KEY DEVELOPMENTS

• 10.1 Product Launches/Developments
• 10.2 Mergers and Acquisitions
• 10.3 Business Expansions
• 10.4 Partnerships and Collaborations

11 Appendix

• 11.1 Related Research